Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes.

Literature DB >> 8612195

Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes.

L C Harrison¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1995 PMID： 8612195 PMCID： PMC2230010

Source DB: PubMed Journal: Mol Med ISSN： 1076-1551 Impact factor: 6.354

× No keyword cloud information.

28 in total

Review 1. The murine autoimmune diabetes model: NOD and related strains.

Authors: H Kikutani; S Makino
Journal: Adv Immunol Date: 1992 Impact factor: 3.543

2. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.

Authors: L C Harrison; S X Chu; H J DeAizpurua; M Graham; M C Honeyman; P G Colman
Journal: J Clin Invest Date: 1992-04 Impact factor: 14.808

3. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy.

Authors: M A Atkinson; N K Maclaren; R Luchetta
Journal: Diabetes Date: 1990-08 Impact factor: 9.461

Review 4. Can we really predict IDDM?

Authors: P J Bingley; E Bonifacio; E A Gale
Journal: Diabetes Date: 1993-02 Impact factor: 9.461

5. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals.

Authors: C F Gotfredsen; K Buschard; E K Frandsen
Journal: Diabetologia Date: 1985-12 Impact factor: 10.122

6. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.

Authors: H J De Aizpurua; Y M Wilson; L C Harrison
Journal: Proc Natl Acad Sci U S A Date: 1992-10-15 Impact factor: 11.205

7. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.

Authors: G Rudy; N Stone; L C Harrison; P G Colman; P McNair; V Brusic; M B French; M C Honeyman; B Tait; A M Lew
Journal: Mol Med Date: 1995-09 Impact factor: 6.354

Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes.

Review 1. The murine autoimmune diabetes model: NOD and related strains.

2. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.

3. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy.

Review 4. Can we really predict IDDM?

5. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals.

6. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.

7. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.

8. Insulin antibodies in insulin-dependent diabetics before insulin treatment.

Review 9. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited.

Review 10. Intranasal administration of insulin to humans.

1. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes.

2. Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus.

Review 3. T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.